MARIMED INC. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- MARIMED INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2025-03-31 was $4.28M.
- MARIMED INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-09-30 was $2.90M.
- MARIMED INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-06-30 was $15.82M.
- MARIMED INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- MARIMED INC. stock issued during period, value, conversion of convertible securities for fiscal 2025 was $4.28M.
- MARIMED INC. stock issued during period, value, conversion of convertible securities for fiscal 2023 was $18.73M.
- MARIMED INC. stock issued during period, value, conversion of convertible securities for fiscal 2021 was $1.36M, a 86.53% decline from fiscal 2020.
- MARIMED INC. stock issued during period, value, conversion of convertible securities for fiscal 2020 was $10.08M.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2025-12-31 | $4.28M 10-K · filed 2026-03-12 | |
| 2025-03-31 | $4.28M 10-Q · filed 2026-08-13 | |
| 2023-12-31 | $18.73M 10-K · filed 2025-03-06 | |
| 2023-09-30 | $2.90M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $15.82M 10-Q · filed 2024-11-07 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | $1.36M 10-K · filed 2023-03-03 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $4.27M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $6.42M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $1.36M 10-Q · filed 2022-05-10 | $9.63M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $2.91M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-16 | $10.08M 10-K · filed 2022-03-16 |
| 2020-09-30 | $2.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | |
| 2020-06-30 | $3.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | |
| 2020-03-31 | $1.80M 10-Q · filed 2021-05-17 | |
| 2019-09-30 | $5.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-29 | |
| 2016-12-31 | $995.43K 10-K · filed 2017-04-17 |